Does Immunotherapy Late in the Day Affect Survival in Melanoma?
MedPage Today) — Advanced melanoma patients with more immune checkpoint inhibitor infusions administered late in the day appeared to have worse survival outcomes, the single-center MEMOIR (Melanoma Outcomes Following Immunotherapy) study found…
Read more
